e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
Role of the biomarkers in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
M. Bafadhel, M. McCormick, S. Saha, V. Mistry, S. McKenna, P. Dodson, A. Lloyd, P. Rugman, P. Newbold (Leicester, Loughborough, Sheffield, United Kingdom)
Source:
Annual Congress 2011 - Role of the biomarkers in airway diseases
Session:
Role of the biomarkers in airway diseases
Session type:
Poster Discussion
Number:
4796
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bafadhel, M. McCormick, S. Saha, V. Mistry, S. McKenna, P. Dodson, A. Lloyd, P. Rugman, P. Newbold (Leicester, Loughborough, Sheffield, United Kingdom). Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Eur Respir J 2011; 38: Suppl. 55, 4796
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Multiple inflammatory hits and the pathogenesis of severe airway disease
Source: Eur Respir J 2006; 27: 884-888
Year: 2006
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012
Sputum cytokine profiling according to the type of airway inflammation in obstructive pulmonary diseases
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Therapeutic responses in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008
Clinical and inflammatory features of exacerbations of occupational chronic obstructive pulmonary disease
Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Year: 2017
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Systemic inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 5S-13S
Year: 2003
Bacterial bronchopulmonary infection-induced exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 258s
Year: 2002
Small airway inflammation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001
Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Peripheral lung remodelling in asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 893-894
Year: 2004
Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies
Source: Eur Respir J 2008; 31: 70-77
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept